Systemic Injustices in Opioid Treatment Access and Outcomes, A Two-Tiered Crisis
Toorjo Bhattacharya
13/10/2026
Opioids are a class of analgesic drugs that are commonly prescribed for pain management. Opioids do, however, possess an immense addictive potential due to their activation of the brain's reward pathways. This can oftentimes result in physical dependence and fatal overdose.
Over the past two decades, the United States has experienced an unprecedented public health emergency characterized by increasing rates of opioid use disorder (OUD) and overdose mortality.
However, the crisis doesn't affect everyone equally. It impacts low-income and minority communities at a much deeper level. This systematic literature review goes into investigating structural disparities in access to medications for opioid use disorder (MOUD) and long-term therapeutic outcomes using evidence that has been collected from 19 different studies. These studies revealed that Black and Latino patients are less likely to receive office-based buprenorphine therapy compared to White patients, who receive it at higher rates. Instead of buprenorphine therapy, minority communities are far more likely to be channeled into tightly restricted methadone clinics that require daily, in-person visits and long commutes. These daily hurdles are the cause of severe drop-off rates from treatment programs and many patients leave treatment within six months. This results in higher relapse rates and rising synthetic opioid overdose deaths in urban areas.
Ultimately, this literature review points to a two-tiered system kept in place by policy barriers and unequal access to proper medications for opioid use disorder. Fixing this crisis requires actions like legislative reform, broader access to medications at local pharmacies, and opioid reduction programs.
